Ligand Pharmaceuticals (LGND) Cash from Discontinued Operations (2010 - 2013)

Ligand Pharmaceuticals has disclosed Cash from Discontinued Operations across 3 years of filings, most recently posting 642000.0 for Q1 2013.

• Cash from Discontinued Operations for Q1 2013 came in at 642000.0, down 221.0% year-over-year; the trailing twelve-month figure through Dec 2013 was 642000.0 (up 28.67% YoY), and the FY2013 annual result was 642000.0, up 28.67% from the prior year.
• Cash from Discontinued Operations came in at 642000.0 for Q1 2013 at Ligand Pharmaceuticals, down from 350000.0 in the prior quarter.
• In the past five years, Cash from Discontinued Operations ranged from a high of 1000.0 in Q3 2010 to a low of 642000.0 in Q1 2013.
• The 3-year median for Cash from Discontinued Operations is 275000.0 (2012), against an average of 260833.33.
• Peak annual rise in Cash from Discontinued Operations reached 221.0% in 2013, while the deepest fall reached 221.0% in 2013.
• Ligand Pharmaceuticals' Cash from Discontinued Operations stood at 22000.0 in 2010, then sank by 1490.91% to 350000.0 in 2012, then sank by 83.43% to 642000.0 in 2013.
• The last three Cash from Discontinued Operations figures came in at 642000.0 (Q1 2013), 350000.0 (Q4 2012), and 350000.0 (Q3 2012), per Business Quant data.